C

Crinetics Pharmaceuticals
D

CRNX

56.050
USD
-0.97
(-1.70%)
Market Closed
Volume
29,903
EPS
-4
Div Yield
-
P/E
-15
Market Cap
5,197,943,993
OverviewSignalsIdeasNews
Related Instruments
    A
    ADPT
    -0.51000
    (-9.14%)
    5.07000 USD
    B
    BNGO
    -0.00920
    (-3.60%)
    0.24620 USD
    C
    CRIS
    -0.04000
    (-1.00%)
    3.96000 USD
    H
    HRTX
    -0.04500
    (-3.61%)
    1.20000 USD
    L
    LPX
    -0.470
    (-0.42%)
    111.970 USD
    M
    MGNX
    -0.23000
    (-6.04%)
    3.58000 USD
    P
    PTCT
    -3.110
    (-7.34%)
    39.270 USD
    S
    STOK
    -1.900
    (-13.63%)
    12.040 USD
    X
    XERS
    -0.14000
    (-4.58%)
    2.92000 USD
    More
News

Title: Crinetics Pharmaceuticals

Sector: Healthcare
Industry: Biotechnology
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.